by Alex Kadhim
This real-world study demonstrates that lifileucel TIL therapy can deliver strong responses in advanced melanoma, with high response rates and encouraging survival among treated patients. However,...
by Alex Kadhim
New findings highlight proteostasis as a key driver of T cell differentiation and antitumor function, identifying protein-quality control as a critical factor in preventing T cell exhaustion. By...
by ASTCT Talks and Oncology on the Go
This ASTCT and CancerNetwork® collaboration recaps key hematologic oncology advances from the 2026 ASCO Annual Meeting, featuring expert discussion from a live X Spaces session. Highlights...
by Hemalatha Rangarajan, MD
Dr. Hemalatha Rangarajan of Nationwide Children’s Hospital (Columbus, Ohio) discusses new CIBMTR findings on pediatric and young adult AML, showing that extramedullary disease (EMD) at...
by Jacob Keller, Chenyu Lin
Cell and gene therapy (CGT) is rapidly transforming modern medicine, requiring scalable infrastructure to support its growing use across cancer and non-malignant diseases. This article highlights...
by Alex Kadhim
Researchers from the University of Lausanne and University Hospital of Zurich in Switzerland demonstrate that PD‑1–targeted CAR‑T cells can selectively reduce HIV reservoir cells and delay...